Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer immunotherapy
cancer immunotherapy
Amgen barrels into a $540M immunotherapy deal with Advaxis
Endpoints
Tue, 08/2/16 - 08:55 am
Amgen
Advaxis
cancer immunotherapy
Celgene to collaborate with tiny Jounce on cancer immunotherapy
Yahoo/Reuters
Tue, 07/19/16 - 09:58 am
Celgene
Jounce Therapeutics
cancer immunotherapy
Will Merck & Co Keytruda Surpass Bristol-Myers Opdivo In Immunotherapies Race?
Bidness, ETC
Fri, 06/17/16 - 10:17 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
cancer immunotherapy
Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?
Motley Fool
Tue, 06/14/16 - 10:08 am
Pfizer
M&A
Agenus
cancer immunotherapy
Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup
Forbes
Mon, 06/13/16 - 10:36 am
Mitchell Gold
Dendreon
cancer immunotherapy
Alpine Immune Sciences
Immunotherapy At ASCO: The Cancer Research Institute On What To Watch
Forbes
Fri, 06/3/16 - 10:43 am
ASCO 2016
cancer immunotherapy
MacroGenics scores drug licensing deal worth up to $740 million
Bizjournals.com
Fri, 05/20/16 - 10:23 am
Macrogenics
Janssen
MGD015
cancer immunotherapy
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Pfizer cancer drug shows promise in combo with Merck's Keytruda
Yahoo/Reuters
Thu, 05/19/16 - 09:39 am
Pfizer
Merck
Keytruda
utomilumab
cancer immunotherapy
clinical trials
This Big Pharma Stock Is Set to Profit From an Immunology Bonanza
TheStreet.com
Mon, 04/25/16 - 06:40 pm
AbbVie
cancer immunotherapy
Roche Sees Its First Cancer Immunotherapy Winning U.S. Nod Soon
Bloomberg
Tue, 04/19/16 - 09:51 am
Roche
cancer immunotherapy
FDA
atezolizumab
Bristol Myers Set to Enhance Dominance in Immunotherapies Market
Bidness, ETC
Sat, 04/16/16 - 04:10 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Hodgkin's lymphoma
Drug giant plots Bay area expansion, 150 more jobs
Bizjournals.com
Thu, 04/14/16 - 01:29 pm
Bristol-Myers Squibb
hirings
expansion
California
cancer immunotherapy
Sean Parker sets up $250 mln cancer immunotherapy collaboration
Yahoo/Reuters
Wed, 04/13/16 - 09:54 am
Sean Parker
cancer immunotherapy
Cholesterol pill boosts cancer immunotherapy, at least in mice
Yahoo/Reuters
Thu, 03/17/16 - 05:03 pm
Opdivo
Keytruda
Avasimibe
Merck
Bristol-Myers Squibb
cancer immunotherapy
Pfizer
Rivals chase Bristol-Myers in cancer immunotherapy drug race
Yahoo/Reuters
Fri, 02/26/16 - 11:09 am
Bristol-Myers Squibb
cancer immunotherapy
Roche
AstraZeneca
Merck
Opdivo
With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
Bizjournals.com
Wed, 02/10/16 - 10:30 am
ARMO BioSciences
venture capital
Alphabet
Celgene
cancer immunotherapy
Novartis provides $170M to kick off Surface Oncology partnership
Fierce Biotech
Mon, 01/11/16 - 11:56 am
Novartis
Surface Oncology
cancer immunotherapy
Merck's Keytruda gets presidential lift as Jimmy Carter announces he's cancer-free
BioPharma Dive
Mon, 12/7/15 - 12:09 pm
Merck
Keytruda
brain cancer
cancer immunotherapy
Amgen and Merck & Co to Collaborate for Immunotherapy Cancer
Bidness, ETC
Fri, 12/4/15 - 08:20 pm
Amgen
Merck
Keytruda
cancer immunotherapy
Blincyto
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »